Portfolio Diversification
Range
Most Diversified
32 instruments
August 19, 2025
Least Diversified
16 instruments
August 9, 2025
Average
29.9 instruments
Most Consistent Holdings
Top 5
BIIB100%
REGN100%
SRPT100%
RGEN100%
CRSP100%
Position Sizing
Analysis
Market Exposure
Analysis
Top Sectors
Top 5
Top Countries
Top 5
Holdings over time
(Since January 1, 2022)
| Instrument | Avg. Exposure | Current Exposure | Time Holding | Last Closed |
|---|---|---|---|---|
 Vertex (VRTX) | 3.81% | 2.82% | 99.16% | - |
 Alnylam (ALNY) | 3.62% | 5.41% | 99.16% | - |
 Amgen (AMGN) | 3.57% | 3.12% | 99.16% | - |
| Regeneron (REGN) | 3.56% | 2.33% | 100% | - |
| Repligen (RGEN) | 3.46% | 2.47% | 100% | - |
 Bristol-Myers Squibb (BMY) | 3.46% | 2.37% | 99.09% | - |
| Sarepta (SRPT) | 3.45% | 0.45% | 100% | - |
 Gilead Sciences (GILD) | 3.45% | 3.56% | 99.01% | - |
 Johnson & Johnson (JNJ) | 3.44% | 3.55% | 99.16% | - |
 Jazz Pharmaceuticals (JAZZ) | 3.39% | 3.05% | 99.16% | - |
| CRISPR Therapeutics (CRSP) | 3.33% | 3.9% | 100% | - |
 IQVIA (IQV) | 3.24% | 2.74% | 99.09% | - |
| Biogen (BIIB) | 3.21% | 2.73% | 100% | - |
 Pfizer (PFE) | 3.13% | 2.72% | 99.16% | - |
 Charles River Labs (CRL) | 2.98% | 2.57% | 99.09% | - |
 BeiGene (ONC) | 2.76% | 5.47% | 73.19% | - |
 Bio-Techne (TECH) | 2.67% | 0% | 80.65% | 12/26/2024 |
 AstraZeneca (AZN) | 2.48% | 3.57% | 73.19% | - |
 SpringWorks Therapeutics (SWTX) | 2.47% | 0% | 68.24% | 7/3/2025 |
 United Therapeutics (UTHR) | 2.47% | 3.21% | 72.12% | - |
 Blueprint Medicines (BPMC) | 2.42% | 0% | 69.84% | 7/23/2025 |
 GlaxoSmithKline (GSK) | 2.42% | 3.45% | 71.9% | - |
 Catalent (CTLT) | 2.34% | 0% | 66.72% | 6/26/2024 |
 Agilent (A.US) | 2.34% | 2.99% | 69% | - |
 uniQure (QURE) | 2.33% | 3.02% | 73.95% | - |
 Intellia (NTLA) | 2.3% | 0% | 80.65% | 12/26/2024 |
 Moderna (MRNA) | 2.14% | 0% | 79.82% | 12/26/2024 |
 Sanofi (SNY) | 2.06% | 2.79% | 60.17% | - |
 Ascendis Pharma (ASND) | 1.64% | 4.26% | 46.23% | - |
 Alkermes (ALKS) | 1.57% | 2.93% | 46.38% | - |
 BioMarin (BMRN) | 1.38% | 2.52% | 46.38% | - |
 Verve Therapeutics (VERV) | 1.12% | 0% | 30.31% | 7/29/2025 |
 Novartis (NVS) | 0.98% | 2.89% | 27.95% | - |
 Bruker (BRKR) | 0.87% | 0% | 25.89% | 1/9/2023 |
 Revvity (RVTY) | 0.85% | 0% | 25.89% | 1/9/2023 |
 Vir (VIR) | 0.76% | 0% | 25.89% | 1/9/2023 |
 BioNTech SE (BNTX) | 0.7% | 0% | 25.89% | 1/9/2023 |
 Syneos Health Inc (SYNH) | 0.69% | 0% | 25.89% | 1/9/2023 |
 Catalyst Pharmaceuticals (CPRX) | 0.63% | 2.75% | 15.38% | - |
 Ionis (IONS) | 0.61% | 4.9% | 19.19% | - |
 2Seventy Bio (TSVT) | 0.61% | 0% | 25.89% | 1/9/2023 |
 Fate Therapeutics (FATE) | 0.59% | 0% | 26.73% | 1/9/2023 |
 Exelixis (EXEL) | 0.57% | 0% | 13.94% | 12/26/2024 |
 Arcturus Therapeutics (ARCT) | 0.55% | 3.16% | 19.27% | - |
 Twist Bioscience (TWST) | 0.49% | 1.54% | 19.19% | - |
 Allogene (ALLO) | 0.47% | 0% | 13.1% | 6/26/2024 |
 Caribou Biosciences (CRBU) | 0.41% | 0% | 13.1% | 6/26/2024 |
 Editas (EDIT) | 0.35% | 0% | 13.94% | 6/26/2024 |
 Pacific Biosciences (PACB) | 0.22% | 0% | 13.94% | 6/26/2024 |
 ProQR (PRQR) | 0.2% | 0% | 25.89% | 1/9/2023 |
 10X Genomics (TXG) | 0.08% | 2.89% | 2.28% | - |
 Bayer (BAYN.DE) | 0.05% | 0% | 0.84% | 1/11/2022 |
 Takeda (TAK) | 0.04% | 0% | 0.84% | 1/11/2022 |
 Beam Therapeutics (BEAM) | 0.04% | 3.24% | 1.45% | - |
 Sangamo (SGMO) | 0.02% | 0% | 0.84% | 1/11/2022 |
 Invitae Corp (NVTAQ) | 0.02% | 0% | 0.84% | 1/11/2022 |
 Cellectis SA (CLLS) | 0.02% | 0% | 0.84% | 1/11/2022 |
 Adverum (ADVM) | 0.01% | 0% | 0.84% | 1/11/2022 |
Exposure over time
Exposure by Sector
Exposure by Country
Portfolio Time Machine
Portfolio date
01
01
2025
| Instrument | Invested | Value |
|---|---|---|
| Arcturus Therapeutics (ARCT) | 3.2% | 3.45% |
| uniQure (QURE) | 1.25% | 3.42% |
| Biogen (BIIB) | 4.45% | 3.41% |
| BeiGene (ONC) | 4.09% | 3.4% |
| Sanofi (SNY) | 3.21% | 3.33% |
| Jazz Pharmaceuticals (JAZZ) | 3.75% | 3.33% |
| Regeneron (REGN) | 3.05% | 3.33% |
| Pfizer (PFE) | 5.32% | 3.33% |
| Charles River Labs (CRL) | 5.14% | 3.32% |
| Sarepta (SRPT) | 2.42% | 3.32% |
| GlaxoSmithKline (GSK) | 3.2% | 3.31% |
| Johnson & Johnson (JNJ) | 3.69% | 3.31% |
| AstraZeneca (AZN) | 3.37% | 3.3% |
| Vertex (VRTX) | 2.05% | 3.3% |
| Amgen (AMGN) | 2.87% | 3.3% |
| BioMarin (BMRN) | 4.27% | 3.29% |
| IQVIA (IQV) | 3.99% | 3.29% |
| Gilead Sciences (GILD) | 2.45% | 3.29% |
| Repligen (RGEN) | 4.1% | 3.28% |
| Ascendis Pharma (ASND) | 3.2% | 3.27% |
| SpringWorks Therapeutics (SWTX) | 2.39% | 3.27% |
| Bristol-Myers Squibb (BMY) | 3.51% | 3.27% |
| United Therapeutics (UTHR) | 3.2% | 3.25% |
| Alkermes (ALKS) | 3.09% | 3.24% |
| Alnylam (ALNY) | 2.16% | 3.24% |
| Verve Therapeutics (VERV) | 2.8% | 3.23% |
| Blueprint Medicines (BPMC) | 1.95% | 3.23% |
| CRISPR Therapeutics (CRSP) | 4.42% | 3.22% |
| Ionis (IONS) | 3.2% | 3.22% |
| Twist Bioscience (TWST) | 3.2% | 3.19% |